Lantern Pharma (LTRN) Short Interest Ratio & Short Volume → Memorial Day Sale! Get 90% OFF Behind the Markets! (From Behind the Markets) (Ad) Free LTRN Stock Alerts $6.27 +0.04 (+0.64%) (As of 05/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Lantern Pharma Short Interest DataCurrent Short Interest484,300 sharesPrevious Short Interest497,300 sharesChange Vs. Previous Month-2.61%Dollar Volume Sold Short$2.47 millionShort Interest Ratio1.5 Days to CoverLast Record DateApril 30, 2024Outstanding Shares10,759,000 sharesFloat Size7,870,000 sharesShort Percent of Float6.15%Today's Trading Volume103,922 sharesAverage Trading Volume118,228 sharesToday's Volume Vs. Average88% Short Selling Lantern Pharma ? Sign up to receive the latest short interest report for Lantern Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLTRN Short Interest Over TimeLTRN Days to Cover Over TimeLTRN Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Lantern Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024484,300 shares $2.47 million -2.6%6.2%1.5 $5.10 4/15/2024497,300 shares $2.97 million +18.2%6.3%1.6 $5.97 3/31/2024420,900 shares $3.70 million +191.1%5.3%1.5 $8.80 3/15/2024144,600 shares $1.26 million +112.7%1.8%0.6 $8.70 2/29/202468,000 shares $327,080.00 +14.1%0.9%0.5 $4.81 2/15/202459,600 shares $238,996.00 -14.2%0.8%1.6 $4.01 Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/202469,500 shares $293,290.00 -4.3%0.9%1.6 $4.22 1/15/202472,600 shares $295,482.00 +17.1%1.0%1.6 $4.07 12/31/202362,000 shares $265,360.00 -65.7%0.8%1.4 $4.28 12/15/2023180,500 shares $776,150.00 -20.1%2.4%4.3 $4.30 11/30/2023226,000 shares $892,700.00 +25.0%3.0%5.9 $3.95 11/15/2023180,800 shares $725,008.00 +19.7%2.4%5.1 $4.01 10/31/2023151,000 shares $374,480.00 -2.6%2.0%5.8 $2.48 10/15/2023155,000 shares $509,950.00 +0.1%2.1%5.9 $3.29 9/30/2023154,800 shares $527,868.00 -0.3%2.1%4.9 $3.41 9/15/2023155,200 shares $630,112.00 -3.5%2.1%4.1 $4.06 8/31/2023160,800 shares $726,816.00 +2.9%2.2%3.8 $4.52 8/15/2023156,200 shares $729,454.00 +9.4%2.1%3.6 $4.67 7/31/2023142,800 shares $661,164.00 -2.9%1.9%3.3 $4.63 7/15/2023147,100 shares $728,145.00 +5.2%2.0%3.6 $4.95 6/30/2023139,900 shares $789,036.00 +0.1%1.9%3.9 $5.64 6/15/2023139,800 shares $826,218.00 -0.1%1.9%4.6 $5.91 5/31/2023139,900 shares $728,879.00 -0.9%1.9%4.8 $5.21 5/15/2023141,200 shares $748,360.00 +0.7%1.9%5.2 $5.30 4/30/2023140,200 shares $686,980.00 -2.4%2.1%5.6 $4.90 4/15/2023143,600 shares $722,308.00 -0.4%2.1%5.1 $5.03 3/31/2023144,200 shares $696,486.00 +0.9%2.1%4.7 $4.83 3/15/2023142,900 shares $661,627.00 +0.4%2.1%3.7 $4.63 2/28/2023142,400 shares $781,761.76 -0.8%2.1%3.9 $5.49 2/15/2023143,500 shares $777,770.00 -14.3%2.0%4.1 $5.42 1/31/2023167,400 shares $1.01 million -2.0%2.3%2.9 $6.02 1/15/2023170,800 shares $935,984.00 +15.7%2.3%3 $5.48 12/30/2022147,600 shares $891,504.00 -1.0%2.0%2.6 $6.04 12/15/2022149,100 shares $814,086.00 +2.8%2.0%2.9 $5.46 11/30/2022145,000 shares $725,000.00 -2.1%2.0%3 $5.00 11/15/2022148,100 shares $827,879.00 -3.0%1.8%3.1 $5.59 10/31/2022152,700 shares $639,813.00 -1.0%1.9%3.5 $4.19 10/15/2022154,300 shares $742,183.00 +57.9%2.0%6.3 $4.81 9/30/202297,700 shares $467,006.00 +53.6%1.2%2.5 $4.78 9/15/202263,600 shares $318,636.00 -2.8%0.8%1.7 $5.0141 banks launch ‘crypto dollar’ (Ad)Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). 8/31/202265,400 shares $338,118.00 -26.9%0.8%1.8 $5.17 8/15/202289,500 shares $581,750.00 -5.3%1.1%2.4 $6.50 7/31/202294,500 shares $484,785.00 +59.6%1.2%2.5 $5.13 7/15/202259,200 shares $319,088.00 -7.2%0.8%1.6 $5.39 6/30/202263,800 shares $364,298.00 -18.0%0.9%2.9 $5.71 6/15/202277,800 shares $390,556.00 -13.3%1.1%3.5 $5.02 5/31/202289,700 shares $519,363.00 -40.4%1.2%4 $5.79 5/15/2022150,500 shares $880,425.00 -6.2%2.1%5.9 $5.85 4/30/2022160,400 shares $955,984.00 -12.1%2.2%6.2 $5.96 4/15/2022182,400 shares $1.25 million -3.0%2.5%5.2 $6.88 3/31/2022188,000 shares $1.34 million -9.7%2.5%4.1 $7.15 3/15/2022208,200 shares $1.27 million -7.0%2.8%3.2 $6.10 2/28/2022223,900 shares $1.38 million +0.2%2.9%2.9 $6.16 2/15/2022223,400 shares $1.52 million -4.0%2.9%2.7 $6.81 1/31/2022232,700 shares $1.55 million -5.7%3.0%2.6 $6.65 1/15/2022246,800 shares $1.79 million +13.4%3.2%2.7 $7.27 12/31/2021217,700 shares $1.74 million +15.0%2.8%2.6 $7.98 12/15/2021189,300 shares $1.48 million -17.7%2.4%2.3 $7.81 11/30/2021230,100 shares $1.94 million +20.5%3.0%3.4 $8.44 11/15/2021190,900 shares $1.84 million -15.6%2.5%2.5 $9.66 10/29/2021226,200 shares $2.31 million +8.1%2.9%2.8 $10.21 10/15/2021209,300 shares $2.10 million -10.6%2.7%2.6 $10.01 9/30/2021234,000 shares $2.62 million -10.9%3.0%2.7 $11.18 9/15/2021262,700 shares $3.17 million -2.7%3.4%3.4 $12.08 8/31/2021270,100 shares $3.81 million +0.2%3.5%3.6 $14.09 8/13/2021269,700 shares $3.40 million -5.2%3.5%4.3 $12.60 7/30/2021284,600 shares $3.67 million -14.2%3.7%4.9 $12.90 7/15/2021331,800 shares $4.43 million -0.8%4.3%5.4 $13.35 6/30/2021334,500 shares $4.88 million -15.8%4.3%5.1 $14.60 6/15/2021397,100 shares $5.98 million +0.5%5.1%5.1 $15.07 5/28/2021395,000 shares $5.97 million +27.0%5.1%3.9 $15.12 5/14/2021311,100 shares $4.29 million +0.6%4.0%2.6 $13.80 4/30/2021309,400 shares $4.89 million +33.7%4.0%2.3 $15.81 4/15/2021231,500 shares $3.72 million +1.5%3.0%1.4 $16.08 3/31/2021228,000 shares $4.11 million +40.0%3.0%1 $18.02 3/15/2021162,900 shares $3.09 million +45.3%2.2%0.8 $18.97 2/26/2021112,100 shares $1.89 million -6.6%1.6%0.6 $16.87 2/12/2021120,000 shares $2.23 million +41.3%1.7%0.7 $18.61 1/29/202184,900 shares $1.26 million -50.2%1.3%0.6 $14.86 1/15/2021170,400 shares $2.47 million No Change4.4%1.4 $14.51 LTRN Short Interest - Frequently Asked Questions What is Lantern Pharma's current short interest? Short interest is the volume of Lantern Pharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 484,300 shares of LTRN short. 6.15% of Lantern Pharma's shares are currently sold short. Learn More on Lantern Pharma's current short interest. What is a good short interest ratio for Lantern Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LTRN shares currently have a short interest ratio of 2.0. Learn More on Lantern Pharma's short interest ratio. What is a good short interest percentage for Lantern Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.15% of Lantern Pharma's floating shares are currently sold short. Is Lantern Pharma's short interest increasing or decreasing? Lantern Pharma saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 484,300 shares, a decrease of 2.6% from the previous total of 497,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lantern Pharma's float size? Lantern Pharma currently has issued a total of 10,759,000 shares. Some of Lantern Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lantern Pharma currently has a public float of 7,870,000 shares. How does Lantern Pharma's short interest compare to its competitors? 6.15% of Lantern Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lantern Pharma: LAVA Therapeutics (0.86%), Journey Medical Co. (4.07%), MediciNova, Inc. (0.46%), Rallybio Co. (9.67%), Landos Biopharma, Inc. (0.05%), Leap Therapeutics, Inc. (5.57%), Checkpoint Therapeutics, Inc. (11.50%), Mural Oncology plc (11.13%), Reneo Pharmaceuticals, Inc. (13.80%), Celularity Inc. (5.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lantern Pharma stock? Short selling LTRN is an investing strategy that aims to generate trading profit from Lantern Pharma as its price is falling. LTRN shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lantern Pharma? A short squeeze for Lantern Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LTRN, which in turn drives the price of the stock up even further. How often is Lantern Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LTRN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: LVTX Short Squeeze DERM Short Squeeze MNOV Short Squeeze RLYB Short Squeeze LABP Short Squeeze LPTX Short Squeeze CKPT Short Squeeze MURA Short Squeeze RPHM Short Squeeze CELU Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LTRN) was last updated on 5/25/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy Sykes41 banks launch ‘crypto dollar’Stansberry ResearchThe 1,000X Crypto PlaybookTrue Market InsidersBiden FINISHED On June 13th?Paradigm Press$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyJust $9 for a Year of Winning Market InsightsBehind the MarketsUrgent Nvidia WarningAltimetryNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.